Question

Difficulty: Very hardGastroenterology and Hepatology

A 42-year-old man presents to a gastroenterology clinic with a 1-year history of severe, burning epigastric pain and chronic high-volume watery diarrhea. The abdominal pain frequently awakens him at night and is only minimally relieved by high-dose pantoprazole, which he has taken reliably for the past 6 months. He has no personal or family history of nephrolithiasis, hypercalcemia, or pituitary disease. An upper endoscopy performed prior to referral revealed remarkably prominent gastric folds and multiple deep ulcerations in the duodenal bulb and the descending duodenum. The physician highly suspects Zollinger-Ellison syndrome (ZES) and plans to initiate a comprehensive diagnostic and management algorithm.

Arrange the following steps in the strictly correct chronological order for the evaluation and definitive management of this patient's condition.

  1. 1Discontinue proton pump inhibitor therapy for at least one week
  2. 2Measure fasting serum gastrin concentration and gastric aspirate pH
  3. 3Administer an intravenous secretin stimulation test
  4. 4Perform a Gallium-68 DOTATATE PET/CT scan
  5. 5Proceed with surgical exploration and tumor resection

Answer

The correct sequential order is: Discontinue proton pump inhibitor therapy -> Measure fasting serum gastrin and gastric pH -> Administer an intravenous secretin stimulation test -> Perform a Gallium-68 DOTATATE PET/CT scan -> Proceed with surgical exploration and tumor resection.
The management of suspected Zollinger-Ellison syndrome follows a rigorous, stepwise algorithm. First, profound acid suppression (PPIs) must be discontinued because it causes physiological hypergastrinemia, which confounds testing. Second, a fasting serum gastrin is measured alongside gastric pH; an elevated gastrin in an acidic environment (pH < 2) rules out achlorhydria. Third, if the gastrin level is elevated but not definitively diagnostic (110–1,000 pg/mL), a secretin stimulation test is required to confirm the diagnosis, as secretin paradoxically stimulates gastrinomas. Fourth, once biochemically confirmed, somatostatin receptor imaging (DOTATATE PET/CT) is used to localize the tumor. Finally, if the tumor is localized and the patient does not have MEN1 syndrome (sporadic ZES), surgical resection is performed for a potential cure.

Step-by-Step Solution

1
Discontinue proton pump inhibitor therapy for at least one week
Eliminates factitious (secondary) hypergastrinemia.
PPIs disrupt the negative feedback loop by suppressing gastric acid, leading to elevated gastrin levels. Testing while on a PPI renders the results uninterpretable.
2
Measure fasting serum gastrin concentration and gastric aspirate pH
Establishes baseline biochemical parameters.
Hypergastrinemia must be documented alongside an acidic stomach (pH < 2). If the pH is > 2, the hypergastrinemia is appropriate (e.g., due to achlorhydria/pernicious anemia).
3
Administer an intravenous secretin stimulation test
Confirms the biochemical diagnosis of a gastrinoma.
If the initial gastrin level is not definitively diagnostic (>1,000 pg/mL), secretin is given. Secretin suppresses normal G cells but paradoxically stimulates gastrinoma cells to release gastrin.
4
Perform a Gallium-68 DOTATATE PET/CT scan
Anatomically localizes the tumor.
Localization imaging should never precede biochemical confirmation. Gastrinomas highly express somatostatin receptors, making this the most sensitive imaging modality.
5
Proceed with surgical exploration and tumor resection
Provides definitive cure.
Because this patient has no history of MEN1 (which usually presents with multiple, unresectable tumors), surgical enucleation of the localized sporadic tumor is the final therapeutic step.

Key Concept

The diagnostic algorithm for Zollinger-Ellison syndrome requires sequential biochemical confirmation (off acid suppression) prior to anatomical localization and surgical management.
Estimated Time:2m 0s
Rate this question